Paradigm Biopharmaceuticals | PAR - Cost Of Sales

Stock Price
0.26
Daily Change
0.01 1.96%
Monthly
-7.14%
Yearly
-38.82%
Q1 Forecast
0.25

Paradigm Biopharmaceuticals reported AUD1.88K in Cost of Sales for its fiscal semester ending in June of 2025.





Cost Of Sales Change Date
Avita Medical AUD 3.3M 166K Dec/2025
Medical Developments International AUD 7.09M 4.91M Dec/2025
Neuren Pharmaceuticals AUD 7.45M 6.56M Jun/2025
Pacific Edge NZD 280K 0 Mar/2024
Telix Pharmaceuticals AUD 221.36M 20.78M Dec/2025